Article
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade.
Current oncology (Toronto, Ont.) - 5 Jul 2023
Yang Jiayu, Yang Lin, Tordon Bryan, Bucher Oliver, Nugent Zoann, Landego Ivan, Bourrier Nicole, Uminski Kelsey, Brown Kevin, Squires Mandy, Marshall Aaron J, Katyal Sachin, Mahmud Salah, Decker Kathleen, Geirnaert Marc, Dawe David E, Gibson Spencer B, Johnston James B, Banerji Versha
Abstract excerpt
FISH cytogenetics, TP53 sequencing, and IGHV mutational status are increasingly used as prognostic and predictive markers in chronic lymphocytic leukemia (CLL), particularly as components of the CLL International Prognostic Index (CLL-IPI) and in directing therapy with novel agents. However, testing outside of clinical trials is not routinely available in Canada. As a centralized CLL clinic at CancerCare...
Topics
Join the communities discussing this publication.